{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:16:33Z","timestamp":1790788593310,"version":"4.1.0"},"reference-count":131,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.ijantimicag.2010.11.029","type":"journal-article","created":{"date-parts":[[2011,2,3]],"date-time":"2011-02-03T04:15:39Z","timestamp":1296706539000},"page":"491-503","source":"Crossref","is-referenced-by-count":69,"title":["Clinical implications of \u03b2-lactam\u2013aminoglycoside synergism: systematic review of randomised trials"],"prefix":"10.1016","volume":"37","author":[{"given":"Ronit","family":"Marcus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mical","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Elphick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Leibovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00000441-197012000-00006","article-title":"Antimicrobial activity of the carbenicillin\u2013gentamicin combination against Gram-negative bacilli","volume":"260","author":"Klastersky","year":"1970","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0010","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0002-9343(86)90490-0","article-title":"Aminoglycosides plus \u03b2-lactams against Gram-negative organisms. Evaluation of in vitro synergy and chemical interactions","volume":"80","author":"Giamarellou","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0015","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/AAC.13.5.813","article-title":"Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins","volume":"13","author":"Neu","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0020","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/jac\/dkl044","article-title":"The role of aminoglycosides in combination with a \u03b2-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials","volume":"57","author":"Falagas","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0025","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/bmj.38028.520995.63","article-title":"\u03b2 Lactam monotherapy versus \u03b2 lactam\u2013aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials","volume":"328","author":"Paul","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0030","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bmj.326.7399.1111","article-title":"\u03b2 Lactam monotherapy versus \u03b2 lactam\u2013aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis","volume":"326","author":"Paul","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/430912","article-title":"Effect of aminoglycoside and \u03b2-lactam combination therapy versus \u03b2-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials","volume":"41","author":"Bliziotis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0040","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(04)01108-9","article-title":"Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis","volume":"4","author":"Safdar","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1473-3099(02)00241-4","article-title":"Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis","volume":"2","author":"Furno","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0050","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.CCM.0000297956.27474.9D","article-title":"Empiric antibiotic therapy for suspected ventilator-associated pneumonia: a systematic review and meta-analysis of randomized trials","volume":"36","author":"Aarts","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0055","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/CCM.0b013e3181e96b91","article-title":"A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic\/meta-regression study","volume":"38","author":"Kumar","year":"2010","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.ijantimicag.2010.11.029_bib0060","first-page":"CD002007","article-title":"Single versus combination intravenous antibiotic therapy for people with cystic fibrosis","author":"Elphick","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0065","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions, version 5.0.2 [updated September 2009]. London, UK: The Cochrane Collaboration; 2008. http:\/\/www.cochrane-handbook.org [accessed 20 December 2010].","DOI":"10.1002\/9780470712184"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0070","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0075","unstructured":"Review Manager (RevMan) [Computer program]. Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008."},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0080","unstructured":"Iten AC, Eggimann A, Siegrist H, Francioli P. The addition of netilmicin (NET) to imipenem (IMIP) does not prevent the emergence of bacteria resistant (R) to IMIP during treatment (ttt) of severe infections. In: 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1992; Anaheim, CA. Washington, DC: ASM Press; 1992. p. 198 [abstract no. 522]."},{"issue":"Suppl. 4","key":"10.1016\/j.ijantimicag.2010.11.029_bib0085","doi-asserted-by":"crossref","first-page":"S741","DOI":"10.1093\/clinids\/7.Supplement_4.S741","article-title":"Aztreonam plus vancomycin (plus amikacin) vs. moxalactam plus ticarcillin for the empiric treatment of febrile episodes in neutropenic cancer patients","volume":"7","author":"Jones","year":"1985","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0090","first-page":"1968","article-title":"Antibiotic therapy protocol using ceftazidime 3g\/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients [in French]","volume":"17","author":"Marie","year":"1988","journal-title":"Presse Med"},{"issue":"Suppl. D","key":"10.1016\/j.ijantimicag.2010.11.029_bib0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jac\/41.suppl_4.57","article-title":"Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients","volume":"41","author":"Marie","year":"1998","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl.","key":"10.1016\/j.ijantimicag.2010.11.029_bib0100","first-page":"160","article-title":"Double-blind, randomized, clinical trial comparing monotherapy with piperacillin\u2013tazobactam versus piperacillin\u2013tazobactam plus amikacin as empiric therapy for febrile neutropenic cancer patients","volume":"8","author":"Micozzi","year":"2000","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0105","unstructured":"Padoan R, Cambisano W, Costantini D, Crossignani R, Giunta A. Pseudomonas pulmonary infections in cystic fibrosis: ceftazidime vs ceftazidime plus sisomicin vs piperacillin plus sisomicin. In: 9th International Cystic Fibrosis Congress; 9\u201315 June 1984; Brighton, UK. Chichester, UK: John Wiley; 1984. Poster 4.21."},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0110","first-page":"275","article-title":"Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial","volume":"2","author":"Pico","year":"1993","journal-title":"Eur J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0115","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/infdis\/147.3.559","article-title":"Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin\u2013tobramycin, azlocillin\u2013tobramycin, and azlocillin\u2013placebo","volume":"147","author":"McLaughlin","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/00365548609032319","article-title":"Immediate and prolonged clinical efficacy of ceftazidime versus ceftazidime plus tobramycin in chronic Pseudomonas aeruginosa infection in cystic fibrosis","volume":"18","author":"Pedersen","year":"1986","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0125","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1128\/AAC.21.2.268","article-title":"Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease","volume":"21","author":"Thompson","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0002-9343(46)90026-5","article-title":"The treatment of subacute bacterial endocarditis with antibiotics","volume":"1","author":"Hunter","year":"1946","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0135","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0022-3476(85)80264-X","article-title":"Management of acute pulmonary exacerbations in cystic fibrosis: a critical appraisal","volume":"106","author":"Nelson","year":"1985","journal-title":"J Pediatr"},{"issue":"Suppl. 7","key":"10.1016\/j.ijantimicag.2010.11.029_bib0140","doi-asserted-by":"crossref","first-page":"S1572","DOI":"10.1093\/clinids\/11.Supplement_7.S1572","article-title":"Antibiotic therapy for the febrile granulocytopenic cancer patient: combination therapy vs. monotherapy","volume":"11","author":"Wade","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0145","first-page":"85","article-title":"Monotherapy for empiric treatment of fever in granulocytopenic cancer patients","volume":"80","author":"Wade","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0002-9343(85)90103-2","article-title":"Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer","volume":"78","author":"Wade","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0155","first-page":"490","article-title":"Management of diabetic foot in a Jordanian hospital","volume":"11","author":"Al-Ebous","year":"2005","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0160","first-page":"83","article-title":"Comparative study of meropenem vs ceftazidime plus amikacin in the treatment of mechanical ventilator-associated pneumonia","volume":"22","author":"Alvarez Lerma","year":"1998","journal-title":"Med Intensiva"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0165","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1128\/AAC.23.1.36","article-title":"Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin","volume":"23","author":"Coppens","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0170","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/BF01954122","article-title":"A comparison of ceftazidime and aminoglycoside based regimens as empirical treatment in 1316 cases of suspected sepsis in the newborn. European Society for Paediatric Infectious Diseases\u2013Neonatal Sepsis Study Group","volume":"151","author":"de Louvois","year":"1992","journal-title":"Eur J Pediatr"},{"issue":"Suppl. 4","key":"10.1016\/j.ijantimicag.2010.11.029_bib0175","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1007\/BF01645864","article-title":"Results of several different controlled studies with ceftazidime in the treatment of infections in immunosuppressed patients [in German]","volume":"15","author":"de Pauw","year":"1987","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0180","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/jama.212.10.1667","article-title":"The treatment of pyoderma in children","volume":"212","author":"Esterly","year":"1970","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0185","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0028-2243(90)90051-2","article-title":"Suspected postpartum endometritis: a controlled clinical trial of single-agent antibiotic therapy with Amox-CA (Augmentin) vs. ampicillin\u2013metronidazole\u00b1aminoglycoside","volume":"36","author":"Fernandez","year":"1990","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0190","first-page":"21","article-title":"A prospective randomized clinical trial of antimicrobial therapy for soft tissue infections in surgical patients","volume":"9","author":"Gabel-Hughes","year":"1990","journal-title":"Infect Surg"},{"issue":"Suppl.","key":"10.1016\/j.ijantimicag.2010.11.029_bib0195","first-page":"5","article-title":"Prospective randomly controlled trial of three antibiotic combinations for empirical therapy of suspected sepsis in neutropenic cancer patients","volume":"11","author":"Gaya","year":"1975","journal-title":"Eur J Cancer"},{"issue":"Suppl. C","key":"10.1016\/j.ijantimicag.2010.11.029_bib0200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jac\/11.suppl_C.57","article-title":"The results of a randomized trial of empirical antibiotic treatment in febrile neutropenic patients with four \u03b2-lactam\/aminoglycoside combinations","volume":"11","author":"Hann","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0205","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1159\/000239383","article-title":"The administration regimen of isepamicin in patients with chronic respiratory tract infection","volume":"41","author":"Hara","year":"1995","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0210","first-page":"612a","article-title":"Piperacillin\u2013tazobactam plus tobramycin is safe and effective therapy in children with febrile neutropenic episodes who are colonised with Enterobacteriaceae expressing extended spectrum \u03b2-lactamases","volume":"92","author":"Hazel","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0215","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/AAC.2.6.470","article-title":"Clinical significance of in vitro synergism between antibiotics in Gram-negative infections","volume":"2","author":"Klastersky","year":"1972","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0220","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1128\/AAC.29.2.263","article-title":"Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients","volume":"29","author":"Klastersky","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0225","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/1097-0142(197208)30:2<573::AID-CNCR2820300238>3.0.CO;2-O","article-title":"Antibiotic combinations for infections in neutropenic patients. Evaluation of carbenicillin plus either cephalothin or kanamycin","volume":"30","author":"Middleman","year":"1972","journal-title":"Cancer"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0230","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/jac\/24.4.591","article-title":"Prospective comparative trial of short course (four day) and continuous tobramycin in combination with cefoperazone or mezlocillin in febrile, granulocytopenic patients","volume":"24","author":"Pegram","year":"1989","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 43","key":"10.1016\/j.ijantimicag.2010.11.029_bib0235","first-page":"14","article-title":"Four trials of antibiotics in patients with chronic mucopurulent bronchitis","volume":"43","author":"Pines","year":"1967","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0240","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/bmj.2.5607.735","article-title":"Antibiotic regimens in severe and acute purulent exacerbations of chronic bronchitis","volume":"2","author":"Pines","year":"1968","journal-title":"Br Med J"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0245","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJM198608283150905","article-title":"A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia","volume":"315","author":"Pizzo","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0250","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0002-9343(79)90390-5","article-title":"Duration of empiric antibiotic therapy in granulocytopenic patients with cancer","volume":"67","author":"Pizzo","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0255","first-page":"464","article-title":"Leomycin; trial of a combined penicillin\u2013streptomycin preparation in pneumonia [in Danish]","volume":"121","author":"Schaebel","year":"1959","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0260","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJM197105132841904","article-title":"Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia","volume":"284","author":"Schimpff","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0265","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/infdis\/137.1.14","article-title":"Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC International Antimicrobial Therapy Project Group","volume":"137","author":"Schimpff","year":"1978","journal-title":"J Infect Dis"},{"issue":"Suppl. A","key":"10.1016\/j.ijantimicag.2010.11.029_bib0270","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/jac\/36.suppl_A.157","article-title":"Safety and efficacy of meropenem in patients with septicaemia: a randomised comparison with ceftazidime, alone or combined with amikacin","volume":"36","author":"Solberg","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0275","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF02393162","article-title":"Clinical comparison of antibiotic combinations in the treatment of peritonitis and related mixed aerobic\u2013anaerobic surgical sepsis","volume":"4","author":"Stone","year":"1980","journal-title":"World J Surg"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0280","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(72)90567-3","article-title":"Initial therapy with combination of five antibiotics in febrile patients with leukaemia and neutropenia","volume":"1","author":"Tattersall","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0285","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1001\/jama.214.10.1841","article-title":"Clinical and bacteriological evaluation of antibiotic treatment in shigellosis","volume":"214","author":"Tong","year":"1970","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0290","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/0002-9343(81)90324-7","article-title":"Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients","volume":"71","author":"Wade","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0295","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/10428190109064594","article-title":"A randomized prospective multicentre trial of cefpirome versus piperacillin\u2013tazobactam in febrile neutropenia","volume":"42","author":"Bauduer","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0300","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.218.1.62","article-title":"Carbenicillin therapy for Pseudomonas infections","volume":"218","author":"Bodey","year":"1971","journal-title":"JAMA"},{"issue":"Suppl. C","key":"10.1016\/j.ijantimicag.2010.11.029_bib0305","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/jac\/17.suppl_C.203","article-title":"A prospective randomized study comparing the efficacy of Timentin alone or in combination with amikacin in the treatment of febrile neutropenic patients","volume":"17","author":"Bru","year":"1986","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 6","key":"10.1016\/j.ijantimicag.2010.11.029_bib0310","doi-asserted-by":"crossref","first-page":"S320","DOI":"10.1007\/BF01715772","article-title":"Nosocomial pneumonia: comparative multicentre trial between monotherapy with cefotaxime and treatment with antibiotic combinations","volume":"19","author":"Fernandez-Guerrero","year":"1991","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0315","first-page":"628","article-title":"Comparative open study of cefoperazone versus aminoglycosides in bacterial infections treatment","volume":"73","author":"Ferrigno","year":"1986","journal-title":"Prensa Med Argent"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0320","first-page":"9","article-title":"A laboratory and clinical trial of the combined preparation ampicillin\/sulbactam [in Russian]","volume":"36","author":"Finegold","year":"1991","journal-title":"Antibiot Khimioter"},{"issue":"Suppl. 25","key":"10.1016\/j.ijantimicag.2010.11.029_bib0325","first-page":"96","article-title":"Cefamandole alone and combined with gentamicin or tobramycin in the treatment of acute pyelonephritis","author":"Gentry","year":"1980","journal-title":"Scand J Infect Dis Suppl"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0330","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0002-9343(98)00244-7","article-title":"A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin\u2013clavulanate","volume":"105","author":"Gilbert","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0335","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jac\/12.2.175","article-title":"Piperacillin and tobramycin in the treatment of Pseudomonas lung infections in cystic fibrosis","volume":"12","author":"Hoogkamp-Korstanje","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0340","first-page":"481","article-title":"Therapy of febrile neutropenia episodes in systemic hematologic illnesses with new once daily ceftriaxone administration [in German]","volume":"148","author":"Karthaus","year":"1998","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0345","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0195-6701(87)90125-3","article-title":"Empirical treatment of febrile, neutropenic patients with tobramycin and latamoxef","volume":"9","author":"Rhodes","year":"1987","journal-title":"J Hosp Infect"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2010.11.029_bib0350","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.ijantimicag.2005.08.001","article-title":"Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group","volume":"26","author":"Tamura","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0355","first-page":"61","article-title":"Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases [in Japanese]","volume":"53","author":"Urabe","year":"2000","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0360","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00000441-197603000-00006","article-title":"\u03b2-Lactam antibiotics alone or in combination with gentamicin for therapy of Gram-negative bacillary infections in neutropenic patients","volume":"271","author":"Bodey","year":"1976","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0365","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1128\/AAC.26.6.870","article-title":"Single-drug versus combination empirical therapy for Gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia","volume":"26","author":"Piccart","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0370","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archinte.152.2.283","article-title":"A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients","volume":"152","author":"Rolston","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0375","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1086\/322646","article-title":"A multicenter, double-blind, placebo-controlled trial comparing piperacillin\u2013tazobactam with and without amikacin as empiric therapy for febrile neutropenia","volume":"33","author":"Del Favero","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0380","unstructured":"Doyen C, Tempatondele J, Wauters G, Michaux J. A randomized therapeutic trial for ceftazidime versus ceftazidime and amikacin in febrile granulocytopenic patients. In: Spitzy KH, Karrer K, editors. Proceedings of the 13th International Congress of Chemotherapy; 28 August\u20132 September 1983; Vienna, Austria."},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0385","doi-asserted-by":"crossref","unstructured":"Ceftazidime combined with a short or long course of amikacin for empirical therapy of Gram-negative bacteremia in cancer patients with granulocytopenia. The EORTC International Antimicrobial Therapy Cooperative Group. N Engl J Med 1987;317:1692\u20138.","DOI":"10.1056\/NEJM198712313172703"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0390","first-page":"229b","article-title":"Piperacillin\/tazobactam vs. piperacillin\/tazobactam plus amikacin as empiric therapy for fever in neutropenic patients","volume":"90","author":"Esteve","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0395","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF01728894","article-title":"Ceftazidime versus ceftazidime plus tobramycin in febrile neutropenic children","volume":"21","author":"Jacobs","year":"1993","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0400","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0002-9343(86)90258-5","article-title":"Aztreonam therapy in neutropenic patients with cancer","volume":"81","author":"Jones","year":"1986","journal-title":"Am J Med"},{"issue":"Suppl. A","key":"10.1016\/j.ijantimicag.2010.11.029_bib0405","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0195-6701(90)90079-4","article-title":"Ceftazidime monotherapy is as effective as ceftazidime combined with gentamicin in the treatment of febrile neutropenic patients","volume":"15","author":"Kinsey","year":"1990","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0410","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/00000421-199410000-00009","article-title":"A randomized prospective study of imipenem\u2013cilastatin with or without amikacin as an empirical antibiotic treatment for febrile neutropenic patients","volume":"17","author":"Kojima","year":"1994","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0415","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0399-077X(05)80140-4","article-title":"Comparative trial of ceftazidime alone, ceftazidime+amikacin and ceftazidime+vancomycin as empiric therapy of febrile cancer patients with induced prolonged neutropenia","volume":"21","author":"Marie","year":"1991","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0420","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01703442","article-title":"Ceftazidime with or without amikacin for the empiric treatment of localized infections in febrile, granulocytopenic patients","volume":"63","author":"Novakova","year":"1991","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0425","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/mpo.2950150103","article-title":"Randomised study of ticarcillin, cefamandole with or without tobramycin in febrile, neutropenic patients with solid tumors","volume":"15","author":"Page","year":"1987","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0430","first-page":"275","article-title":"Ceftriaxone in the treatment of infections in neutropenic patients","volume":"94","author":"Pasternak","year":"1987","journal-title":"Folha Med"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2010.11.029_bib0435","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1086\/383046","article-title":"Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia","volume":"39","author":"Tamura","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0440","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ajh.10236","article-title":"Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin+aminoglycosides: comparative study","volume":"71","author":"Tamura","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0445","first-page":"165","article-title":"Application of cefepime alone or in combination with amikacin in the empirical treatment of fever in patients with neutropenia","volume":"32","author":"Wrzesien-Kus","year":"2001","journal-title":"Acta Haematol Pol"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0450","first-page":"1300","article-title":"Evaluation of empiric therapy in patients with severe infections complicating hematological malignancies","volume":"41","author":"Yoshida","year":"1993","journal-title":"Chemotherapy (Japan)"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0455","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/157488409787236119","article-title":"Evaluation of efficacy and safety of fixed dose combination of ceftazidime\u2013tobramycin in comparison with ceftazidime in lower respiratory tract infections","volume":"4","author":"Chaudhary","year":"2009","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0460","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2174\/157488408784293660","article-title":"Efficacy and safety evaluation of fixed dose combination of cefepime and amikacin in comparison with cefepime alone in treatment of nosocomial pneumonia patients","volume":"3","author":"Chaudhary","year":"2008","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0465","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/cc4879","article-title":"Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779]","volume":"10","author":"Damas","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0470","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11096-004-7039-6","article-title":"A clinical and economic study of community-acquired pneumonia between single versus combination therapy","volume":"27","author":"Hasali","year":"2005","journal-title":"Pharm World Sci"},{"issue":"Suppl. 4","key":"10.1016\/j.ijantimicag.2010.11.029_bib0475","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1007\/BF01645868","article-title":"Ceftazidime with and without tobramycin versus azlocillin plus tobramycin in the therapy of bronchopulmonary infections in intensive care patients [in German]","volume":"15","author":"Kljucar","year":"1987","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0480","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jac\/9.1.63","article-title":"Effectiveness of mezlocillin and endotracheally administered sisomicin with or without parenteral sisomicin in the treatment of Gram-negative bronchopneumonia","volume":"9","author":"Sculier","year":"1982","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0485","first-page":"170","article-title":"Clinical evaluation of combination therapy of sulbactam\/cefoperazone and aminoglycoside in respiratory tract infections [in Japanese]","volume":"47","author":"Sukoh","year":"1994","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0490","first-page":"1131","article-title":"Imipenem\/cilastatin sodium alone or combined with amikacin sulfate in respiratory infections [in Japanese]","volume":"47","author":"Takamoto","year":"1994","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0495","first-page":"15","article-title":"Evaluation of the association amoxicillin\/sulbactam against amoxicillin\/sulbactam plus gentamicin in children with peritonitis of appendicular origin","volume":"28","author":"Cardozo","year":"2001","journal-title":"Pediatr (Asuncion)"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0500","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1128\/AAC.44.8.2028-2033.2000","article-title":"Monotherapy with a broad-spectrum \u03b2-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group","volume":"44","author":"Dupont","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0505","first-page":"55","article-title":"Comparative study of three antimicrobial drugs protocol (ceftriaxone, gentamicin\/amikacin and metronidazole) versus two antimicrobial drugs protocol (ceftriaxone and metronidazole) in cases of intra-abdominal sepsis","volume":"3","author":"Khan","year":"2005","journal-title":"Kathmandu Univ Med J (KUMJ)"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0510","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/00365549709035880","article-title":"Aminoglycosides do not improve the efficacy of cephalosporins for treatment of acute pyelonephritis in women","volume":"29","author":"Sandberg","year":"1997","journal-title":"Scand J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2010.11.029_bib0515","first-page":"208","article-title":"Imipenem\/cilastatin as empirical treatment of severe infections in compromised patients","volume":"3","author":"Biglino","year":"1991","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0520","first-page":"367","article-title":"Cefotaxime (C) vs cefotaxime+amikacin (C+A) in the treatment of septicemia due to enterobacteria: a multicenter study","volume":"6","author":"Carbon","year":"1987","journal-title":"Chemioterapia"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0525","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1128\/AAC.38.6.1309","article-title":"Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients","volume":"38","author":"Cometta","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0530","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1159\/000239037","article-title":"Randomized comparison of ceftriaxone versus ceftriaxone plus amikacin for the empirical treatment of infections in patients with altered host defense: microbiological and clinical evaluation","volume":"38","author":"D\u2019Antonio","year":"1992","journal-title":"Chemotherapy"},{"issue":"Suppl. A","key":"10.1016\/j.ijantimicag.2010.11.029_bib0535","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jac\/12.suppl_A.101","article-title":"A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients","volume":"12","author":"Fainstein","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0540","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/1097-0142(197302)31:2<331::AID-CNCR2820310210>3.0.CO;2-S","article-title":"Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by Gram-negative rods","volume":"31","author":"Klastersky","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0545","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jama.227.1.45","article-title":"Gram-negative infections in cancer. Study of empiric therapy comparing carbenicillin\u2013cephalothin with and without gentamicin","volume":"227","author":"Klastersky","year":"1974","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0550","first-page":"286","article-title":"Azlocillin versus azlocillin plus amikacin in the treatment of severe infections in intensive care unit patients","volume":"6","author":"Mergoni","year":"1987","journal-title":"Chemioterapia"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0555","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/00365548709018479","article-title":"A prospective randomised comparison of cefotaxime vs. netilmicin vs. cefotaxime plus netilmicin in the treatment of hospitalised patients with serious sepsis","volume":"19","author":"Sage","year":"1987","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0560","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7326\/0003-4819-90-5-789","article-title":"Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers","volume":"90","author":"Abrams","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0565","doi-asserted-by":"crossref","first-page":"496","DOI":"10.7326\/0003-4819-97-4-496","article-title":"Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study","volume":"97","author":"Korzeniowski","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0570","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-125-12-199612150-00005","article-title":"Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial","volume":"125","author":"Ribera","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0575","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1086\/515038","article-title":"Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group","volume":"27","author":"Sexton","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0580","unstructured":"Costantini D, Padoan R, Brienza A, Lodi G, Assael B, Giunta A. Clinical evaluation of carbenicillin and sisomycin alone or in combination in CF patients with pulmonary exacerbations [abstract]. In: Proceedings of the 11th European Cystic Fibrosis Conference; 1982. Karup, Denmark: European Cystic Fibrosis Society; 1982. p. 227."},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0585","unstructured":"Huang N, Palmer J, Braverman S, Keith H, Schidlow D. Therapeutic efficacy of ticarcillin and carbenicillin in patients with cystic fibrosis: a double blind study [abstract]. In: 23rd Cystic Fibrosis Club Abstracts; 14 May 1982. Washington, DC: 1982. p. 124."},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0590","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0007-0971(65)80009-2","article-title":"Treatment of exacerbations of bronchitis with high dosage penicillin and with penicillin plus streptomycin","volume":"59","author":"Lewis","year":"1965","journal-title":"Br J Dis Chest"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0595","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ppul.1950040403","article-title":"Comparison of piperacillin alone versus piperacillin plus tobramycin for treatment of respiratory infections in children with cystic fibrosis","volume":"4","author":"McCarty","year":"1988","journal-title":"Pediatr Pulmonol"},{"issue":"Suppl. B","key":"10.1016\/j.ijantimicag.2010.11.029_bib0600","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jac\/11.suppl_B.195","article-title":"Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis","volume":"11","author":"McLaughlin","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0605","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/00006454-198707000-00006","article-title":"Ceftazidime monotherapy vs. combined therapy in Pseudomonas pulmonary infections in cystic fibrosis","volume":"6","author":"Padoan","year":"1987","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0610","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-3476(77)80790-7","article-title":"Treatment of pulmonary infections in patients with cystic fibrosis: a comparative study of ticarcillin and gentamicin","volume":"90","author":"Parry","year":"1977","journal-title":"J Pediatr"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0615","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-3476(99)70197-6","article-title":"Comparison of a \u03b2-lactam alone versus \u03b2-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis","volume":"134","author":"Smith","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0620","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1046\/j.1523-1755.2002.00509.x","article-title":"Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes","volume":"62","author":"Clermont","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0625","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.41.5.1127","article-title":"Monotherapy versus \u03b2-lactam\u2013aminoglycoside combination treatment for Gram-negative bacteremia: a prospective, observational study","volume":"41","author":"Leibovici","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0630","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00134-008-1363-6","article-title":"Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough","volume":"35","author":"Rodriguez","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0635","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/thx.2006.067595","article-title":"Survey of acute renal failure in patients with cystic fibrosis in the UK","volume":"62","author":"Bertenshaw","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0640","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ppul.21086","article-title":"Renal dysfunction in cystic fibrosis: is there cause for concern?","volume":"44","author":"Soulsby","year":"2009","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0645","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/CCM.0b013e3181eb3ccd","article-title":"Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis","volume":"38","author":"Kumar","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0650","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/dkm193","article-title":"Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials","volume":"60","author":"Vidal","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.11.029_bib0655","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1093\/jac\/dkq373","article-title":"Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia","volume":"65","author":"Paul","year":"2010","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910005558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910005558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T05:16:03Z","timestamp":1559970963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857910005558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":131,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0924857910005558"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.11.029","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}